Categories
Blood Cancer

Living with Multiple Myeloma | Leukemia and Lymphoma Society [Video]

Topics Covered

We invite you to learn more about:

  • New and emerging therapies for myeloma
  • What to do when myeloma relapses
  • CAR T-cell therapy for myeloma
  • The importance of discussing quality-of-life issues with your treatment team

Speaker

Noa Biran, MDAssistant Professor of MedicineJohn Theurer Cancer CenterMultiple Myeloma DivisionHackensack Meridian HealthHackensack, NJ

Program Materials

Transcript will be available soon.

Program Support

Support for this program is provided by Bristol Myers Squibb, Genentech and Biogen, GlaxoSmithKline, Janssen Biotech, and Oncopeptides.

< Back to Webcasts

Watch/Read More
Categories
Blood Cancer

Second-line CAR-T therapy in B-cell lymphoma [Video]

Peter M. Riedell, MD, University of Chicago Medicine, Chicago, IL, shares updates from the Phase III ZUMA-7 trial (NCT03391466) of the anti CD19 axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (r/r) large B-cell lymphoma (LBCL). A superior event-free survival and overall survival were reported in the axi-cel arm and the findings corroborate with data from the Phase III TRANSFORM trial (NCT03575351), demonstrating the potential of CAR T-cell therapy as a second-line option for LBCL. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Categories
Blood Cancer Lung Cancer Pancreatic Cancer Pediatric Cancer

Boy Fighting Leukemia Enjoys Hamburger Dinner With Santa In North Pole CBS Philly [Video]

A 7-year-old Woodland boy diagnosed with leukemia wished to meet Santa Claus and have a hamburger dinner at the North Poleand that wish was granted.

Categories
Blood Cancer Breast Cancer Pancreatic Cancer

Seneca Valley Football Teams Draws Inspiration From Athletic Director Diagnosed With Breast Cancer CBS Pittsburgh [Video]

Seneca Valley High School's football team is learning the greatest lessons in life this year.